[1] |
Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[2] |
Liu Bohan, Huang Junxing.Research progress of solute carriers related genes in malignant tumors[J]. Journal of International Oncology, 2023, 50(5): 280-284. |
[3] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[4] |
Wang Yue, Hu Qun, Hou Yingwei.Research progress in influences of epigenetic modifications on PD-L1 expression in tumors[J]. Journal of International Oncology, 2022, 49(6): 345-348. |
[5] |
Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili.Research progress of avermectins in anti-tumor[J]. Journal of International Oncology, 2022, 49(6): 353-356. |
[6] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[7] |
Pang Jingdan, Du Yingying, Da Jie.Adverse reactions and treatment measures of advanced solid tumors treated with antibody-drug conjugates[J]. Journal of International Oncology, 2022, 49(4): 220-224. |
[8] |
Zeng Yan, Luo Pan, Wang Ziqi, Wu Weili.Mechanism of drug induced ferroptosis in the treatment of head and neck tumors[J]. Journal of International Oncology, 2022, 49(3): 173-176. |
[9] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738. |
[10] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686. |
[11] |
Yang Chi, Luo Changjiang.Research progress on the background of inflammation, immunity and cholesterol metabolism in colorectal cancer[J]. Journal of International Oncology, 2022, 49(10): 630-634. |
[12] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50. |
[13] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
[14] |
Zhang Jing, Huang Shouguo, Xia Ying.Mechanism study of CeRNA regulatory network mediating malignant tumor phenotype[J]. Journal of International Oncology, 2021, 48(9): 544-548. |
[15] |
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414. |